SCHEMBL5154823

SCHEMBL5154823

COc1ccc(-c2ccc(C(=O)N[C@@H](CO)Cc3c[nH]c4ccccc34)cc2)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
MEN1 O00255 2/20 0.59
HPGDS O60760 1/20 0.57
HDAC3 O15379 7/20 0.55
HDAC1 Q13547 7/20 0.55
HDAC2 Q92769 7/20 0.55
HDAC6 Q9UBN7 5/20 0.55
MAPT P10636 3/20 0.54
HPGD P15428 2/20 0.54
ALDH1A1 P00352 1/20 0.54
THRB P10828 1/20 0.54
KDM4E B2RXH2 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CDK4 P11802 3/20 0.54
CCND1 P24385 3/20 0.54
TLR8 Q9NR97 1/20 0.54
TLR7 Q9NYK1 1/20 0.54
HDAC4 P56524 4/20 0.51
HDAC7 Q8WUI4 4/20 0.51
HDAC10 Q969S8 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4601301 0.93 KMT2A (0.58) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL5152158 0.93 KMT2A (0.58) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL5151707 0.92 HDAC3 (0.54) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL5152568 0.91 CDK4 (0.53) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL14557759 0.90 KMT2A (0.59) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL14564889 0.90 KMT2A (0.52) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL5151324 0.89 KMT2A (0.56) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL5151626 0.89 KMT2A (0.56) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL14564880 0.89 KMT2A (0.51) KMT2AMEN1HPGDSHDAC3HDAC1
SCHEMBL4601457 0.88 HDAC3 (0.57) KMT2AMEN1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R KMT2A 916/4885MEN1 410/4885HPGDS 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.